Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Johanna Hilli, MD, PhD

Femme Max 99 ans
Johanna Hilli, MD, PhD MAJ Il y a 5 ans

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events Twenty patients with verified high risk breast cancer will be included in the study. Patients will receive three cycles of docetaxel followed by three cycles of CEF for their adjuvant trea...

Pays Finland
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations